Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |